Today, the U.S. Food and Drug Administration approved Crenessity (crinecerfont) to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like hormone) levels in adults ...
In 2022, Andera Partners, a private equity firm in France took a majority stake in Telecom Design to fuel an ambitious expansion plan under the leadership of incoming CEO Christophe Arnaud. ...